SYNOPSIS Studies in vitro of the sensitivity to trimethoprim and sulphonamides of nine strains of N. asteroides, two strains of N. caviae, and one of N. blackwellii are presented. No unequivocal evidence of synergism was found. Despite this, the inclusion of trimethoprim in the drug regime when sulphonamides are used in the treatment of nocardiosis is suggested on empirical grounds.
In recent years it has been demonstrated that trimethoprim (2,4-diamino-5-(3,4,5-trimethoxybenzyl)-pyrimidine) reacts with sulphonamides in a manner which is strongly synergistic and that drugs, which are themselves bacteriostatic, achieve a bactericidal effect when used together. The pharmacology of this drug combination has been thoroughly evaluated in vitro and in laboratory animals by Bushby and Hitchings (1968) . Darrell, Garrod, and Waterworth (1968) confirmed the in-vitro findings of the above authors and reported favourably on the use of a sulphonamide-trimethoprim regime in successfully treating respiratory infections, urinary tract infection, and Gramnegative septicaemia. More recently, there have been further reports of success in the treatment of urinary tract infection (Gruneberg and Kolbe, 1969; Reeves, Faiers, Pursell, and Brumfitt, 1969) , of neonatal meningitis due to Escherichia coli (Morzaria, Walton, and Pickering, 1969) , and it has been found (Akinkugbe, Lewis, Montefiore, and Okubadejo, 1968) Shuster, Klein, Pribor, and Kozub, 1967) . Peabody and Seabury (1960) , however, in an extensive review of the therapy of actinomycosis and nocardiosis have suggested that better results might be obtained if sulphadiazine were to be used along with another chemotherapeutic drug in the treatment of the latter condition. Trimethoprim would appear on theoretical grounds to be the obvious choice of drug for this purpose, and the following paper, in an attempt to substantiate this theory, presents an account of studies in vitro of the effect of sulphonamide-trimethoprim mixtures on nine strains of Nocardia asteroides, two of N. caviae, and one of N. blackwellii. pH by the addition of N/I NaOH after which it was found possible to readjust the pH to with N/i HC1 without precipitation occurring.
Materials and Methods
From basic dilutions in nutrient broth (Oxoid-CM1) containing 10,000 ,ug/ml, tube dilutions containing 2,000-500 ,ug/ml and 200-6 25 ,ug/ml were prepared for each drug. Aliquots of the 2,000 ,ug/ml solutions of the three drugs were then taken and both the sulphamethoxazole and the sulphadiazine mixed with trimethoprim to give sulphonamide: trimethoprim ratios of 20:1, 10:1, 5:1, and 1:1, and, from each of these 2,000 ,ug/ml mixtures, dilutions ranging from 2,000 to 6-25 ,tg/ml were made as before. Universals containing measured 18 ml aliquots of molten diagnostic sensitivity test agar (Oxoid-CM261) were allowed to cool to about 50°C to 600C and, before pouring, 1 ml of lysed horse blood and 1 ml of one of the antibiotic dilutions were added to each giving a final antibiotic concentration ranging from 100 to 0-312 ,tg/ml.
A measured loopful (0-0025 ml) of a six-hour mechanically agitated culture in nutrient broth of each Nocardia strain was then inoculated on to every plate and the inoculum spread over an area of about 1 sq cm. Tween 80 was added to the broth in later experiments to reduce granularity of the broth culture and make it easier to standardize the dose of organisms, which were usually present in a concentration of 105 to 106/ml. This procedure did not affect the interpretation of the results. Using the above dose, a heavy but not confluent growth was obtained and the minimum inhibitory concentration (MIC) was interpreted as in previous studies, namely, the lowest concentration of antimicrobial that inhibited at least 90 % of the control growth (Bushby and Hitchings, 1968) .
Results
The results, which were read after 48 hours' incubation at 37°C, are detailed in Tables II  and III. From these it can be seen that the sulphonamide MICs are satisfactory and could be quite easily achieved in vivo by standard dosages. Raich, Casey, and Hall (1961) , for example, showed that a blood sulphonamide level of 140 ,ug/ml could be maintained by a dosage of 6 to 8 g of sulphadiazine per day, and Garrod and O'Grady (1968) report a peak plasma level of 100 isg/ml after an initial dose of 4 g of sulphadiazine followed by 1 g four hourly. Stokes (1968) maintains that for most acute infections the average blood antibiotic level should exceed the MIC by a safety factor of 2 or 4, but for actinomycosis (and presumably nocardiosis) the safety factor should be higher. These criteria are satisfied by the present figures which show an average MIC of about 2 5 ,ug/ml with a potential blood level of 100 to 140 ,ug/ml, ie, 20 to 30 times the MIC.
The sensitivity to trimethoprim is disappointing. In other series the average MIC for most of the bacteria tested was of the order of 1 jug/ml Sensitivity of Nocardia to trimethoprim and sulphonamides in vitro or less (Bushby and Hitchings, 1968; Darrell et al, 1968) whereas with the Nocardia in our series the MIC of trimethoprim was 50 ,ug/ml in eight out of the 12 strains tested, 25 ,g/ml in three strains, and 10 ,ug/ml in the remaining strain. As Bushby and Hitchings (1968) were able to obtain peak serum levels of only 2 to 3 ,ug/ml of trimethoprim one hour after giving an oral dose of 250 mg, it must be concluded that the use of trimethoprim alone would be of no value in the treatment of nocardiosis.
In the case of Neisseria gonorrhoeae, it has been shown (Bushby and Hitchings, 1968) that there was a high degree of potentiation of sulphadiazine by trimethoprim despite the fact that these organisms are relatively resistant to the latter drug. The results shown in Tables II  and III We chose to test sulphadiazine as well as sulphamethoxazole because the former has been used most widely in the treatment of nocardiosis (Peabody and Seabury, 1960) . Tested individually, the MIC of sulphadiazine is the same, or twofold higher, than that of sulphamethoxazole, a finding which tallies with that of Neipp (1964) in his survey of comparative activities of sulphonamides in vitro. Sulphadiazine displayed the same lack of marked synergistic activity with trimethoprim as did sulphamethoxazole.
Discussion
At the time of publication, sulphadiazine remains the drug of choice in the treatment of nocardiosis (Strauss et al, 1951; Neu et al, 1967; Shuster et al, 1967) . There has, however, been a recent report of the successful treatment of a case of cerebral nocardiosis using a combination of sulphonamides and cycloserine (Hoeprich, Brandt, and Parker, 1968) , and Vasarinsh (1968) reported the successful treatment of a case of primary cutaneous nocardiosis using a combination of sulphadiazine, erythromycin, and sulfone. The fact that no unequivocal synergism with trimethoprim was seen in vitro was disappointing but might have been expected from the relatively high MIC of the latter for, in their study of urinary tract infection, Reeves et al (1969) showed that the failure of treatment in all species tested was associated with a relatively high resistance to trimethoprim.
On the other hand, Wright and Grimble (1969) found that the cure rate in gonorrhoea was only 30 % when treated with sulphamethoxazole but that when this was combined with trimethoprim the cure rate rose to 80 % even although the MIC of trimethoprim for the gonococcus has been shown to be as high in some cases as that which we found for Nocardia (Bushby and Hitchings, 1968) . Again, Csonka and Knight (1967) 
